SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-132819
Filing Date
2016-11-09
Accepted
2016-11-09 16:32:36
Documents
35
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v452109_10q.htm 10-Q 323205
2 EXHIBIT 31.1 v452109_31-1.htm EX-31.1 9525
3 EXHIBIT 31.2 v452109_31-2.htm EX-31.2 9525
4 EXHIBIT 32.1 v452109_32-1.htm EX-32.1 4038
5 EXHIBIT 32.2 v452109_32-2.htm EX-32.2 4425
  Complete submission text file 0001144204-16-132819.txt   1765324

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20160930.xml EX-101.INS 277558
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20160930.xsd EX-101.SCH 18267
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20160930_cal.xml EX-101.CAL 37741
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20160930_def.xml EX-101.DEF 107182
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20160930_lab.xml EX-101.LAB 156677
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20160930_pre.xml EX-101.PRE 124604
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 161984676
SIC: 2836 Biological Products, (No Diagnostic Substances)